Aster Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$912K Sell
4,125
-248
-6% -$54.1K 0.33% 71
2026
Q2
$852K Buy
+4,373
New +$906K 0.18% 170
2026
Q1
– Sell
-802
Closed -$193K – 1254
2025
Q4
$193K Sell
802
-1,450
-64% -$371K 0.08% 229
2025
Q3
$616K Buy
+2,252
New +$615K 0.31% 74
2025
Q2
– Sell
-744
Closed -$174K – 1492
2025
Q1
$174K Buy
+744
New +$174K 0.03% 516

Other funds holding RMD

Aster Capital Management's RMD Position: Q3 2026 in Review

Aster Capital Management reduced its ResMed (RMD) stake by 5.7% in Q3 2026, selling an estimated $54.1K and leaving 4,125 shares worth $912K. The position accounts for 0.33% of the portfolio, ranked #71.

Aster Capital Management first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Aster Capital Management held 4,125 shares of ResMed worth $912K as of Q3 2026.
  • Aster Capital Management sold 248 ResMed shares in Q3 2026, an estimated $54.1K.
  • ResMed made up 0.33% of Aster Capital Management's portfolio in Q3 2026, its #71 holding.
  • Aster Capital Management first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.